Prenatal n-3 LCPUFAs don't cut IgE-linked disease in children

Prenatal n-3 LCPUFAs don't cut IgE-linked disease in children

(HealthDay)—Prenatal supplementation with omega-3 (n-3) long-chain polyunsaturated fatty acids (LCPUFA) does not reduce immunoglobulin E (IgE)-associated allergic disease in children, according to a study published online May 25 in Pediatrics.

Karen P. Best, R.N., Ph.D., from the South Australian Health and Medical Research Institute in Adelaide, and colleagues assessed 706 children with a family history of allergic disease from the Docosahexaenoic Acid to Optimize Mother Infant Outcome trial at six-year follow-up. Women enrolled in the trial were randomized to n-3 LCPUFA-rich fish oil capsules or vegetable oil capsules.

The researchers found that the percentage of children with any IgE-associated allergic disease did not differ between the n-3 LCPUFA and control groups (31.5 versus 31.5 percent; adjusted relative risk, 1.04; 95 percent confidence interval, 0.82 to 1.33). The percentage of sensitized to house dust mite Dermatophagoides farinae was reduced in the n-3 LCPUFA group (13.4 versus 20.3 percent; adjusted relative risk, 0.67; 95 percent confidence interval, 0.44 to 1.00).

"Prenatal n-3 LCPUFA supplementation did not reduce IgE-associated allergic disease at 6 years of age," the authors write. "Secondary outcomes were suggestive of a protective effect of the intervention on the incidence of D. farinae sensitization."

Two authors disclosed financial ties to the nutrition industry; one author has a patent pending.


Explore further

Supplementation of formula with LCPUFAs ups infant visual acuity

More information: Full Text (subscription or payment may be required)
Journal information: Pediatrics

Copyright © 2016 HealthDay. All rights reserved.

Citation: Prenatal n-3 LCPUFAs don't cut IgE-linked disease in children (2016, May 26) retrieved 25 February 2020 from https://medicalxpress.com/news/2016-05-prenatal-n-lcpufas-dont-ige-linked.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
7 shares

Feedback to editors

User comments